NOVEL DRUGS AND DEVICES FOR IOP LOWERING
Chairpersons:
Dr. Carol Toris, University of Nebraska Medical Center, USA
Dr. Xavier Gasull, Universitat de Barcelona, Spain
Confirmed speakers:
Dr. Herbert Reitsamer, Paracelsus Medical University of Salzburg, Austria
Clinical studies of new glaucoma drainage devices
Dr. Janet Serle, Mount Sinai School of Medicine, USA
Effects of Investigational Compounds On Intraocular Pressure & Mechanism of IOP Reduction in Monkey Eyes
Dr. Carol Toris, University of Nebraska Medical Center, USA
Quantitative Differences Among Novel Glaucoma Devices in a Human Perfusion Model
Dr. Fernando Huete-Toral, Universidad Complutense de Madrid, Spain
Melatonin And Its Analogue 5-Mca-Nat Potentiate The Ocular Hypotensive Effect Mediated By Adrenergic Receptors: Significance For Glaucoma Treatment
Dr. Dan Stamer, Duke University, USA
Unique Response Profile of TM Cells to the novel SEGRA, GW870086X